Analysis of efficacy of SGLT2 inhibitors using semi-mechanistic model

Renal sodium-dependent glucose co-transporter 2 (SGLT2) is one of the most promising targets for the treatment of type 2 diabetes. Two SGLT2 inhibitors, dapagliflozin and canagliflozin, have already been approved for use in USA and Europe; several additional compounds are also being developed for th...

Full description

Saved in:
Bibliographic Details
Main Authors: Oleg eDemin Jr (Author), Tatiana eYakovleva (Author), Dmitry eKolobkov (Author), Oleg eDemin (Author)
Format: Book
Published: Frontiers Media S.A., 2014-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available